Biotechnology
News Category
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC® T-Cell Engager Program
VERAXA Biotech has partnered with ATUM to advance its lead BiTAC® T-cell engager program toward clinical development, marking a critical milestone in ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Diversified Pipeline Targeting Neurodegenerative and Metabolic Disorders
Quantum BioPharma's multifaceted strategy combines clinical-stage therapeutics, consumer wellness products, and strategic investments to address unmet...
Ocumetics Advances Toward Commercialization with Positive Six-Month Clinical Results and Next-Generation Lens Design
Ocumetics Technology Corp. reports positive six-month clinical data from its first-in-human study, supporting progression to Group Two surgeries, whil...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform to Address Biotech Bottleneck
Oncotelic Therapeutics has introduced an AI-driven GMP manufacturing services platform that integrates digital batch records and intelligent robotics,...
Greenland Mines Advances Skaergaard Project with Expert Workshop
Greenland Mines Ltd (NASDAQ: GRML) held a three-day development planning workshop for its Skaergaard project in Greenland, bringing together over 15 i...
VERAXA Biotech Advances Lead BiTAC T-Cell Engager with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program, partnering with ATUM to advance toward IND/CTA-enabling ...
NanoViricides Coverage Initiated with Outperform Rating, $6 Price Target by Noble Capital Markets
Independent analyst Robert LeBoyer of Noble Capital Markets initiated coverage on NanoViricides with an Outperform rating and $6 price target, highlig...
NanoViricides Initiates Coverage with Outperform Rating and $6 Price Target
NanoViricides (NYSE American: NNVC) receives an 'Outperform' rating and $6 price target from Noble Capital Markets, highlighting its broad-spectrum an...
Lantern Pharma Launches AI-Powered ZetaOmics Platform to Accelerate Cancer Research
Lantern Pharma's new ZetaOmics platform introduces an autonomous computational biologist agent that automates complex bioinformatics workflows, expand...
Novartis' $1.5B ADC Acquisition Signals Strong Market Demand, Benefiting VERAXA Biotech
Novartis' acquisition of Myricx Bio for $1.5 billion underscores the robust pharmaceutical demand for innovative antibody-drug conjugate technologies,...
Oncotelic Therapeutics Reports Positive Safety Review for Sapu003 Phase 1b Trial, Plans European Expansion
Oncotelic Therapeutics announced that the independent Safety Review Committee found no dose-limiting toxicities in the initial cohort of its Phase 1b ...
Oragenics Activates All Australian Phase IIa Trial Sites for Concussion Drug ONP-002
Oragenics has activated all three Australian sites for its Phase IIa trial of ONP-002 for mild traumatic brain injury, with no serious adverse events ...
VolitionRx Study Demonstrates Prognostic Value of Nu.Q Cancer Assay in Lung Cancer
New research shows VolitionRx's Nu.Q Cancer Assay can effectively stratify lung cancer patients by mortality risk, supporting its potential to persona...
Greenland Mines Adds Two Geologists to Strengthen Skaergaard Field Campaign
Greenland Mines Ltd (NASDAQ: GRML) announced the addition of Professor Wolfgang Maier and Associate Professor Kristoffer Szilas to its 2026 field camp...
Sustained Release Polymers Market Poised to Reach USD 7.8 Billion by 2036, Driven by Chronic Disease Management and Advanced Drug Delivery
The sustained release polymers market is projected to grow from USD 3.8 billion in 2026 to USD 7.8 billion by 2036 at a CAGR of 7.4%, driven by rising...
VERAXA Biotech Advances BiTAC Pipeline and Partnering Strategy, Aiming for IND by Early 2028
VERAXA Biotech reported progress in its proprietary BiTAC platform and growing pharma interest, with plans to prioritize BiTAC programs while seeking ...
The New Rules of Biotech Now Available in Hardcover and Audiobook
David Craig's 'The New Rules of Biotech' is released in hardcover and audiobook formats, offering a modern guide for biotech founders navigating chang...
VERAXA Biotech Well-Positioned as Novartis’ $1.5B ADC Deal Highlights Pharma Demand for Next-Gen Antibody Therapies
Novartis’ acquisition of Myricx Bio for up to $1.5 billion underscores strong pharmaceutical interest in innovative antibody-drug conjugate technologi...
VERAXA Biotech Advances BiTAC Pipeline and Partnering Strategy in First Half of 2026
VERAXA Biotech reported progress in its BiTAC platform and growing pharma interest, planning to prioritize BiTAC programs while monetizing non-BiTAC a...
VERAXA Biotech Highlights BiTAC Pipeline Progress and Partnering Strategy in First Half 2026 Update
VERAXA Biotech AG provided a corporate update showcasing its proprietary BiTAC platform advancement, pipeline expansion, and strategic focus on partne...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech has begun cell line development for its BiTAC T-cell engager therapy, aiming to improve tumor selectivity and reduce toxicity in cancer...
Gut Microbiome Found to Influence Immunotherapy Efficacy in Liver Cancer Patients
A comprehensive review reveals that the gut microbiome significantly affects how liver cancer patients respond to immunotherapy, offering potential fo...
LIXTE Biotechnology Completes Merger with NOMAD, Rebrands as NOMAD Power Solutions to Focus on Utility-Scale Battery Storage
LIXTE Biotechnology Holdings merged with NOMAD Transportable Power Systems, changing its name to NOMAD Power Solutions and shifting focus to deployabl...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech has begun cell line development for its lead BiTAC T-cell engager program through a collaboration with ATUM, aiming to advance this inn...
VERAXA Biotech (VRXA) Positioned in Active Antibody Therapeutics Deal Market
The article highlights how strategic licensing and collaboration deals in antibody-drug conjugates and T-cell engagers are creating value for platform...
Quantum BioPharma Highlights MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma executive co-chair Anthony Durkacz discussed the company's lead multiple sclerosis drug Lucid-MS and its alcohol metabolism accelera...
VERAXA Biotech AG Targets Antibody Therapeutics Deals as Sector Activity Surges
The article highlights strong deal activity in antibody-drug conjugates and T-cell engagers, positioning VERAXA Biotech AG's platform for potential st...
Quantum BioPharma Outlines MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman discusses the company's lead multiple sclerosis drug candidate Lucid-MS and its alcohol metabolism accelerat...
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes for Workplace Safety
MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, utilizing voice analysis and a...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer Amid Key Clinical Milestones
Annovis Bio has promoted Dr. Cheng Fang to chief scientific officer as the company prepares for top-line data from its pivotal Phase 3 Alzheimer’s stu...
Onco-Innovations Announces CAD$5 Million Private Placement to Advance Cancer Therapies
Onco-Innovations Limited has signed a term sheet for a CAD$5 million private placement with institutional investors to fund its ONC010 program and Syn...
Onco-Innovations Partners with Nanosoft to Advance Manufacturing Development of Lead Cancer Drug Candidate ONC010
Onco-Innovations Limited collaborates with Nanosoft Polymers to optimize and scale the manufacturing of its nanoparticle-formulated PNKP inhibitor ONC...
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
GeoVax comments on the U.S. government's recent procurement of additional ACAM2000 smallpox vaccine, reinforcing the strategic importance of sustained...
Active Hybrid Humidification Incubator Market Set to Reach $229.2 Million by 2036
Driven by demand for precision-controlled cell culture environments, the active hybrid humidification incubator market is projected to grow at a 9.8% ...
Helix BioPharma Strengthens Executive Team Ahead of U.S. Listing and Next Clinical Phase
Helix BioPharma appoints Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its planned U.S. exchange listi...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam announced early completion of patient enrollment in its ALIGN-ACS pilot study for heart attack detection using its 3D ECG technology, potent...
Cardio Diagnostics Holdings Leverages Epigenetics to Reveal Hidden Heart Disease Risks
Cardio Diagnostics Holdings (CDIO) uses epigenetic testing to uncover cardiovascular risks beyond genetics, highlighting how lifestyle and environment...
TechForce Robotics Expands Robotics-as-a-Service into Laboratory Automation with Oncotelic Therapeutics Deployment
TechForce Robotics has deployed its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking its entry into pharmaceutical and lab...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma announced a robustness study for its intranasal PTSD treatment SPC-15, which could pave the way for FDA guidance and Phase 1 trials.
Onco-Innovations Advances Manufacturing and Development of Novel PNKP Inhibitors for Hard-to-Treat Cancers
Onco-Innovations Ltd. achieves kilogram-scale production of its lead drug candidate ONC010 and partners with Nanosoft Polymers for drug delivery optim...
Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development
Creative Enzymes introduces an AI-powered platform that reduces enzyme development cycles and enhances industrial scalability, addressing critical bot...
Amerigo Scientific Launches High-Quality iPSC-Derived Cells to Boost Biomedical Research and Cell Therapy
Amerigo Scientific released high-purity iPSC-derived cells and engineered reporter lines to support disease modeling, drug screening, and cell therapy...
Creative Biolabs Advances Drug Discovery with Custom Oligosaccharide Synthesis and Glycan Characterization
Creative Biolabs integrates chemical, enzymatic, and chemoenzymatic synthesis with comprehensive glycan analysis to provide structurally validated oli...
Quantum BioPharma Hits Key Midpoint in Multiple Sclerosis Imaging Study
Quantum BioPharma announced that its collaborative imaging study with Massachusetts General Hospital has reached the halfway point in patient enrollme...
SUIC and VisionRenu Sign MOU to Advance AI Biotechnology and U.S. Capital Market Expansion
SUIC Worldwide Holdings and VisionRenu Biomedical Technology have signed a strategic MOU to collaborate on AI-powered biotechnology, precision medicin...
Cardio Diagnostics Leverages Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings uses epigenetics to assess cardiovascular risk beyond genetics, offering insights into lifestyle impacts and potential sol...
Oncotelic Therapeutics Publishes Peer-Reviewed Validation of Deciparticle Platform
Oncotelic Therapeutics and Sapu Nano published a peer-reviewed study validating their Deciparticle nanoparticle platform, which enables intravenous de...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Trial of TNX-102 SL for Major Depressive Disorder
Tonix Pharmaceuticals has enrolled the first patient in its HORIZON Phase 2 trial evaluating TNX-102 SL as a first-line monotherapy for major depressi...